Literature DB >> 23153579

Ischemic conditioning protects the rat retina in an experimental model of early type 2 diabetes.

Ezequiel M Salido1, Damián Dorfman, Melina Bordone, Mónica S Chianelli, María Inés Keller Sarmiento, Marcos Aranda, Ruth E Rosenstein.   

Abstract

Diabetic retinopathy is a leading cause of acquired blindness in adults, mostly affected by type 2 diabetes mellitus (T2DM). We have developed an experimental model of early T2DM in adult rats which mimics some features of human T2DM at its initial stages, and provokes significant retinal alterations. We investigated the effect of ischemic conditioning on retinal changes induced by the moderate metabolic derangement. For this purpose, adult male Wistar rats received a control diet or 30% sucrose in the drinking water, and 3 weeks after this treatment, animals were injected with vehicle or streptozotocin (STZ, 25mg/kg). Retinal ischemia was induced by increasing intraocular pressure to 120 mm Hg for 5 min; this maneuver started 3 weeks after vehicle or STZ injection and was weekly repeated in one eye, while control eyes were submitted to a sham procedure. Fasting and postprandial glycemia, and glucose, and insulin tolerance tests were analyzed. At 12 weeks of treatment, animals which received a sucrose-enriched diet and STZ showed significant differences in metabolic tests, as compared with control groups. Brief ischemia pulses in one eye and a sham procedure in the contralateral eye did not affect glucose metabolism in control or diabetic rats. Ischemic pulses reduced the decrease in the electroretinogram a-wave, b-wave, and oscillatory potential amplitude, and the increase in retinal lipid peroxidation, NOS activity, TNFα, Müller cells glial fibrillary acidic protein, and vascular endothelial growth factor levels observed in diabetic animals. In addition, ischemic conditioning prevented the decrease in retinal catalase activity induced by T2DM. These results indicate that induction of ischemic tolerance could constitute a fertile avenue for the development of new therapeutic strategies to treat diabetic retinopathy associated with T2DM.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23153579     DOI: 10.1016/j.expneurol.2012.11.006

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  4 in total

1.  Adaptive Plasticity in the Retina: Protection Against Acute Injury and Neurodegenerative Disease by Conditioning Stimuli.

Authors:  Jeffrey M Gidday
Journal:  Cond Med       Date:  2018-02-15

Review 2.  MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy.

Authors:  Bruce A Berkowitz; David Bissig; Oliver Dutczak; Shannon Corbett; Rob North; Robin Roberts
Journal:  Expert Opin Med Diagn       Date:  2013-06-21

Review 3.  Induction of ischemic tolerance as a promising treatment against diabetic retinopathy.

Authors:  Ruth E Rosenstein; Diego C Fernandez
Journal:  Neural Regen Res       Date:  2014-09-01       Impact factor: 5.135

4.  Effect of sevoflurane preconditioning on light-induced retinal damage in diabetic rats.

Authors:  Daniela Adriana Iliescu; Alexandra Ciubotaru; Mihai Aurelian Ghiţă; Adrian Dumitru; Leon Zăgrean
Journal:  Rom J Ophthalmol       Date:  2018 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.